ALZN
Price
$2.08
Change
+$0.12 (+6.12%)
Updated
Nov 24 closing price
Capitalization
7.91M
Intraday BUY SELL Signals
AXON
Price
$524.60
Change
+$2.61 (+0.50%)
Updated
Nov 24 closing price
Capitalization
41.4B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALZN vs AXON

Header iconALZN vs AXON Comparison
Open Charts ALZN vs AXONBanner chart's image
Alzamend Neuro
Price$2.08
Change+$0.12 (+6.12%)
Volume$96.59K
Capitalization7.91M
Axon Enterprise
Price$524.60
Change+$2.61 (+0.50%)
Volume$1.02M
Capitalization41.4B
ALZN vs AXON Comparison Chart in %
ALZN
Daily Signal:
Gain/Loss:
AXON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALZN vs. AXON commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and AXON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (ALZN: $2.08 vs. AXON: $524.60)
Brand notoriety: ALZN and AXON are both not notable
ALZN represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ALZN: 72% vs. AXON: 124%
Market capitalization -- ALZN: $7.91M vs. AXON: $41.4B
ALZN [@Biotechnology] is valued at $7.91M. AXON’s [@Aerospace & Defense] market capitalization is $41.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.58B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $310.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B. The average market capitalization across the [@Aerospace & Defense] industry is $21.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 5 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 5 bullish, 5 bearish.
  • AXON’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than AXON.

Price Growth

ALZN (@Biotechnology) experienced а -10.54% price change this week, while AXON (@Aerospace & Defense) price change was -3.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was -3.19%, and the average quarterly price growth was +68.21%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.27%. For the same industry, the average monthly price growth was -9.44%, and the average quarterly price growth was +23.71%.

Reported Earning Dates

AXON is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+1.27% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($41.4B) has a higher market cap than ALZN($7.91M). AXON YTD gains are higher at: -11.731 vs. ALZN (-80.077). AXON has higher annual earnings (EBITDA): 341M vs. ALZN (-6.17M). AXON has more cash in the bank: 2.23B vs. ALZN (5.62M). ALZN has less debt than AXON: ALZN (301K) vs AXON (2.05B). AXON has higher revenues than ALZN: AXON (2.39B) vs ALZN (0).
ALZNAXONALZN / AXON
Capitalization7.91M41.4B0%
EBITDA-6.17M341M-2%
Gain YTD-80.077-11.731683%
P/E RatioN/A166.01-
Revenue02.39B-
Total Cash5.62M2.23B0%
Total Debt301K2.05B0%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
39
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNAXON
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signal:
Gain/Loss:
AXON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GXUS53.480.30
+0.56%
Goldman Sachs MarketBeta(R) Ttl IntEqETF
VSGX68.990.31
+0.45%
Vanguard ESG International Stock ETF
GBF105.740.23
+0.22%
iShares Government/Credit Bond ETF
RBLD73.95N/A
N/A
First Trust Alerian US NextGen InfrasETF
LGCF32.75N/A
N/A
Themes US Cash Flow Champions ETF

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+6.12%
SRPT - ALZN
49%
Loosely correlated
+6.90%
VRAX - ALZN
46%
Loosely correlated
+1.76%
SNSE - ALZN
41%
Loosely correlated
+2.96%
ASBP - ALZN
38%
Loosely correlated
+4.62%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+0.50%
TECH - AXON
61%
Loosely correlated
+3.19%
VCYT - AXON
58%
Loosely correlated
+6.23%
BEAM - AXON
57%
Loosely correlated
+6.44%
SEER - AXON
56%
Loosely correlated
-1.02%
ADPT - AXON
56%
Loosely correlated
+9.94%
More